Back to Journals » Clinical Ophthalmology » Volume 5

23-gauge pars plana vitrectomy for management of posteriorly dislocated crystalline lens

Authors Cho M, Chan RVP

Published 8 December 2011 Volume 2011:5 Pages 1737—1743

DOI https://doi.org/10.2147/OPTH.S22331

Review by Single anonymous peer review

Peer reviewer comments 3



Minhee Cho, RV Paul Chan
Weill Cornell Medical College, Department of Ophthalmology, New York, NY, USA

Purpose: Management of posteriorly dislocated crystalline lens has traditionally been performed with a standard 20-gauge vitrectomy system. This study demonstrates the use of a 23-gauge vitrectomy system for removal of retained lens fragments secondary to spontaneous dislocation or complicated cataract extraction.
Methods: A retrospective, noncomparative, interventional consecutive case series at a single university medical center.
Results: Fourteen eyes of 14 patients underwent a 23-gauge vitrectomy for removal of retained lens. Mean age was 75 years. Mean logMAR (logarithm of minimum angle of resolution) visual acuity was 1.47 (Snellen equivalent 20/600) preoperatively and 0.37 (Snellen equivalent 20/50) postoperatively. A 20-gauge fragmatome was used in 64% of cases. The mean time to the best post-vitrectomy acuity was 4.9 weeks. The mean healing time was 25 days (6–48 days). Post-vitrectomy complications included choroidal detachment (two patients), vitreous hemorrhage (two patients), and acute ocular hypertension (two patients). The mean length of follow-up was 6.2 months (1–13 months).
Conclusion: A 23-gauge vitrectomy system alone or in combination with the 20-gauge fragmatome is a safe and efficacious option for removal of dense posteriorly dislocated crystalline lens material.

Keywords: lensectomy, retained lens, PPV

Creative Commons License © 2011 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.